Key statistics

As of last trade GlaxoSmithKline PLC (GSK:LSE) traded at 1,577.80, -3.47% below its 52-week high of 1,634.48, set on Aug 21, 2018.
52-week range
1,235.20Feb 06 20181,634.48Aug 21 2018
Markit short selling activity
Previous close1,562.00
Average volume7.56m
Shares outstanding4.96bn
Free float4.95bn
P/E (TTM)26.31
Market cap77.48bn GBP
EPS (TTM)0.5938
Annual div (ADY)80.00
Annual div yield (ADY)5.12%
Div ex-dateNov 15 2018
Div pay-dateJan 10 2019
Data delayed at least 20 minutes, as of Nov 19 2018 12:50 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on GlaxoSmithKline PLC shares was Buy at 1,503.00 on 05 Nov 2018Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.